Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sirius Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Sirius Therapeutics

Sirius Therapeutics

Series B

San Diego-based Sirius Therapeutics innovates RNAi therapies for cardiovascular diseases.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Sirius Therapeutics, based in San Diego, California, is a pioneering biotechnology company dedicated to developing RNA interference (RNAi) therapies for cardiovascular diseases. The company's mission is to leverage RNAi technology to create innovative medical solutions that address significant cardiovascular risks globally. By focusing on novel RNAi therapies, Sirius aims to change the future of cardiovascular disease treatment and improve patient outcomes worldwide.

Sirius Therapeutics has made significant strides in advancing its RNAi therapies, including the recent milestone of dosing the first subject in a clinical trial in China. This achievement underscores the company's commitment to global healthcare innovation and its potential impact on cardiovascular disease management. Through its cutting-edge research and development efforts, Sirius Therapeutics is poised to make a substantial contribution to the field of biotechnology and patient care.

Sirius Therapeutics - Similar Companies

Sirnaomics logo

Sirnaomics

sirnaomics.com

Silence Therapeutics logo

Silence Therapeutics

Arcturus Therapeutics Holdings logo

Arcturus Therapeutics Holdings

arcturusrx.com

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

Orbital Therapeutics logo

Orbital Therapeutics

Nextrna Therapeutics logo

Nextrna Therapeutics

VasoRx logo

VasoRx

vasrx.com

Switch Therapeutics logo

Switch Therapeutics

switchthera.com

Airna logo

Airna

airna.com

Rnaderm Therapeutics logo

Rnaderm Therapeutics

Somagenics logo

Somagenics

somagenics.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Sanegene Bio logo

Sanegene Bio

sanegenebio.com

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Solstice Biologics logo

Solstice Biologics

Sirius Therapeutics - Quick Facts

Who are Sirius Therapeutics' competitors?

Companies similar to Sirius Therapeutics include Sirnaomics, Silence Therapeutics, Arcturus Therapeutics Holdings and Traversa Therapeutics.

When was Sirius Therapeutics founded?

Sirius Therapeutics was founded in 2021.

Where is Sirius Therapeutics' headquarters located?

Sirius Therapeutics' headquarters is located in San Diego, CA, US.

When was Sirius Therapeutics' last funding round?

Sirius Therapeutics' most recent funding round was for $60M (USD) in October 2023.

How much has Sirius Therapeutics raised to-date?

As of Oct 9, 2023, Sirius Therapeutics has raised a total of $60M (USD).

How many employees does Sirius Therapeutics have?

Sirius Therapeutics has 5 employees as of Feb 4, 2024.

Sirius Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • RNAI
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Rnai Therapies
Tags
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified